Teladoc Health, Inc. (TDOC) Stock Price: $7.58-0.49 (-6.07%)
At close: Jun 22, 2026, 4:00 PM ET
The closing share price for Teladoc Health, Inc. (TDOC) stock was $7.58 for Monday, June 22, 2026, down 6.07% on the day.
Longer view (total return, dividends reinvested): past 12 months +9.8% · 3-year avg -31.8%/yr · 5-year avg -45.5%/yr
TDOC Price Chart
TDOC is featured in
TDOC Key Metrics
See All MetricsLAST CLOSE PRICE
$7.58
52-WEEK RANGE
$4.40 - $9.77
BETA
2.14
% FROM 52W HIGH
-22.42%
MARKET CAP
$1.37B
DIVIDEND YIELD
N/A
PE RATIO
trailing TTM
N/A
PE RATIO (FWD)
next-FY estimate
N/A
P/B RATIO
1.02
DEBT / EQUITY
0.75
REVENUE TTM
$2.51B
NET INCOME TTM
-$171.15M
NET PROFIT MARGIN TTM
-6.81%
TTM TOTAL RETURN
+9.81%
3Y TOTAL RETURN
-31.80%
5Y TOTAL RETURN
-45.50%
TDOC Earnings Preview
Next Earnings Date
Jul 29, 2026
36 days away
EPS Estimate
-0.24
Revenue Est.
$614.80M
Last Quarter Results
EPS
$-0.28
vs Estimate
$-0.39
Revenue
$613.85M
vs Estimate
$610.85M
TDOC Analyst Ratings
Consensus Rating
Based on 20 analysts
Average Price Target
$7.40
-2.4% downside
Low
$5.00
Current
$7.58
High
$10.00
TDOC Analyst Estimates
Earnings Per Share (EPS) Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | $-0.22 | $-0.21 | $-0.21 | 2 |
| Q2 2027 | $-0.19 | $-0.19 | $-0.18 | 2 |
| Q3 2027 | $-0.16 | $-0.15 | $-0.15 | 2 |
| Q4 2027 | $-0.11 | $-0.11 | $-0.11 | 2 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | $-0.98 | $-0.64 | $-0.48 | 10 |
| FY 2028 | $-0.91 | $-0.45 | $0.24 | 9 |
Revenue Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | $620.25M | $626.30M | $639.37M | 11 |
| Q2 2027 | $622.26M | $628.33M | $641.44M | 8 |
| Q3 2027 | $629.63M | $635.77M | $649.03M | 8 |
| Q4 2027 | $644.29M | $650.57M | $664.14M | 15 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | $2.46B | $2.54B | $2.61B | 19 |
| FY 2028 | $2.57B | $2.58B | $2.58B | 13 |
Source: FMP Analyst Consensus Estimates. Forward P/E uses the next-fiscal-year consensus EPS estimate (the same value shown in the Key Metrics strip).
Related Stocks
HealthcareTDOC Competitors' Key Metrics
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1TDOC | $1.37B | $7.58 | -6.07% | +9.81% | -45.50% | -5.16% | — |
| 2XRAY | $2.03B | $10.15 | -1.74% | -31.34% | -29.39% | -15.56% | vs TDOC |
| 3SI | $366.44M | $17.77 | -4.20% | N/A | N/A | N/A | vs TDOC |
| 4TMDX | $2.61B | $75.51 | -4.16% | -38.74% | +20.94% | N/A | vs TDOC |
| 5ME | $15.31M | $0.61 | +0.00% | -67.07% | -68.93% | N/A | vs TDOC |
| 6HIMS | $7.48B | $33.54 | -5.44% | -47.61% | +25.21% | N/A | vs TDOC |
TDOC Charts
Valuation Charts
Performance Charts
CAGR Charts
Financial Statement Charts
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- Capital Expenditure
- Acquisitions
- Share Buybacks
- Stock-Based Compensation
- Total Assets
- Total Equity
- Cash & Equivalents
- Accounts Receivable
- Inventory
- PP&E
- Goodwill
- Accounts Payable
- Retained Earnings
- Total Debt
- Long-Term Debt
- Short-Term Debt
About Teladoc Health, Inc.
Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Charles Divita